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Background
Severe right ventricular (RV) dilation and dysfunction
due to chronic pulmonary regurgitation (PR) requires
pulmonary valve replacement (PVR) late after repair of
Tetralogy of Fallot (rTOF). Cardiac magnetic resonance
(CMR) is the gold standard method to evaluate the
pathophysiology after rTOF and the main tool to sup-
port the decision for PVR in asymptomatic patients.
Given the various options available for PVR, we sought
to evaluate the usefulness of CMR to address patients
towards either a surgical or an interventional procedure.
Methods
From March 2008 to August 2013, 84 patients (66 males,
18 females) underwent CMR study after either transanular
or infundibular TOF repair. In addition to RV ventricle
and function evaluation for PVR timing, a 3D navigator
SSFP sequence was performed to assess pulmonary trunk
(PT) length and dimensions at three levels (PV remnant,
mid-portion, bifurcation) and coronary anatomy. The 3D
navigator SSFP sequence was set in mid-diastole in
20 patients and in end-systole in the latter 64. Further-
more, PT expansion was assessed also by balanced SSFP
cine views of the RVOT. Suitability for percutaneous treat-
ment included maximum PT ranging from 19 to 27 mm
and PT length >20 mm. Indications for perventricular
injectable valve implantation consisted of PT diameter
ranging from 15 to 31 mm and PT length >20 mm.
Patients who did not meet such criteria were referred for
surgery, as well as those with RVOT aneurisms, shape
irregularity and/or significant systolic PT expansion.
Results
Twenty patients were addressed to transcatheter PVR,
which was unsuccessful in 10 cases due to the stent coron-
ary compression on RVOT balloon occlusion test (10%)
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Figure 1 The assessment of PT length and dimensions using, respectively, balanced SSFP cine and 3D SSFP navigator sequence.
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and/or excessive PT expansion (90%). The unsuccessful
transcatheter PVR was due to the discrepancy of PT
dimensions between 3D SSFP sequence set in diastole and
catheterization. On the contrary, all cases addressed to
PVR percutaneous on the basis of 3D SSFP sequence set
in end-systole were successful. All remaining patients
(88%) underwent surgery by means of bioprosthesis (54),
homograft (12) and perventricular injectable valve (8)
implantation. No deaths or complications were reported.
Conclusions
3D navigator SSFP sequence set at end-systolic phase is
more reliable in evaluating RV outflow tract measures and
provides the best information to address patients to
percutaneous.
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Figure 2 RVOT in sagittal and coronal plane on catheterization and 3D navigator SSFP sequence.
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